{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:37:01Z","timestamp":1761597421655,"version":"build-2065373602"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1995,1,1]],"date-time":"1995-01-01T00:00:00Z","timestamp":788918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1995,1,1]],"date-time":"1995-01-01T00:00:00Z","timestamp":788918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[1995,1]]},"DOI":"10.4158\/ep.1.1.14","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T23:14:18Z","timestamp":1365203658000},"page":"14-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Autoimmune Addison\u2019s Disease after Treatment With interleukin-2 and Tumor-Infiltrating Lymphocytes"],"prefix":"10.1016","volume":"1","author":[{"given":"Jennifer S.","family":"Wahle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P.","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph L.","family":"Shaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James W.","family":"Findling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP.1.1.14_bb0005","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1126\/science.181845","article-title":"Selective in vitro growth of T lymphocytes from normal human bone marrows","volume":"193","author":"Morgan","year":"1976","journal-title":"Science"},{"key":"10.4158\/EP.1.1.14_bb0010","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM198512053132327","article-title":"Observations on the systemic administration of autologous-lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer","volume":"313","author":"Rosenberg","year":"1985","journal-title":"N Engl J Med"},{"key":"10.4158\/EP.1.1.14_bb0015","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1056\/NEJM198704093161501","article-title":"Progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone","volume":"316","author":"Rosenberg","year":"1987","journal-title":"N Engl J Med"},{"key":"10.4158\/EP.1.1.14_bb0020","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.3489291","article-title":"A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes","volume":"233","author":"Rosenberg","year":"1986","journal-title":"Science"},{"key":"10.4158\/EP.1.1.14_bb0025","doi-asserted-by":"crossref","first-page":"518","DOI":"10.7326\/0003-4819-108-4-518","article-title":"Metastatic renal cancer treated with interleukin-2 and lymphokine-activated killer cells","volume":"108","author":"Fisher","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP.1.1.14_bb0030","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1001\/jama.1986.03380220083027","article-title":"High-dose recombinant interleukin-2 in the treatment of patients with disseminated cancer","volume":"256","author":"Lotze","year":"1986","journal-title":"JAMA"},{"key":"10.4158\/EP.1.1.14_bb0035","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1002\/1097-0142(19861215)58:12<2764::AID-CNCR2820581235>3.0.CO;2-Z","article-title":"Clinical effects and toxicity of interleukin-2 in patients with cancer","volume":"58","author":"Lotze","year":"1986","journal-title":"Cancer"},{"key":"10.4158\/EP.1.1.14_bb0040","doi-asserted-by":"crossref","first-page":"953","DOI":"10.7326\/0003-4819-109-12-953","article-title":"The hemodynamic effects of treatment with interleukin-2 and lymphokine-activated killer cells","volume":"109","author":"Gaynor","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP.1.1.14_bb0045","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/0003-4819-107-2-293","article-title":"The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells","volume":"107","author":"Denicoff","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP.1.1.14_bb0050","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJM198806163182401","article-title":"Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells","volume":"318","author":"Atkins","year":"1988","journal-title":"N Engl J Med"},{"key":"10.4158\/EP.1.1.14_bb0055","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/1097-0142(19900615)65:12<2686::AID-CNCR2820651215>3.0.CO;2-D","article-title":"Hypothyroidism and goiter in a patient during treatment with interleukin-2","volume":"65","author":"Mattijssen","year":"1990","journal-title":"Cancer"},{"key":"10.4158\/EP.1.1.14_bb0060","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/bjc.1990.237","article-title":"Thyroiditis after treatment with interleukin-2 and interferon alpha-2a","volume":"62","author":"Pichert","year":"1990","journal-title":"Br J Cancer"},{"key":"10.4158\/EP.1.1.14_bb0065","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2265.1991.tb03506.x","article-title":"Cytokines and endocrine function: an interaction between the immune and neuroendocrine systems","volume":"35","author":"Imura","year":"1991","journal-title":"Clin Endo"},{"key":"10.4158\/EP.1.1.14_bb0070","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJM198812223192527","article-title":"Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma","volume":"319","author":"Rosenberg","year":"1988","journal-title":"N Engl J Med"},{"key":"10.4158\/EP.1.1.14_bb0075","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0889-8529(18)30478-X","article-title":"Immunogenetics of autoimmune thyroid disorders","volume":"16","author":"Farid","year":"1987","journal-title":"Endocrinol and Metab Clinics of North Amer"},{"key":"10.4158\/EP.1.1.14_bb0080","series-title":"Autoimmune Diseases of the Endocrine System","first-page":"73","author":"Volpe","year":"1990"},{"key":"10.4158\/EP.1.1.14_bb0085","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0140-6736(83)90628-1","article-title":"Aberrant expression of HLA-DR antigen on thyrocytes in Graves\u2019 disease: relevance for autoimmunity","volume":"2","author":"Hanafusa","year":"1983","journal-title":"Lancet"},{"key":"10.4158\/EP.1.1.14_bb0090","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0140-6736(83)90629-3","article-title":"Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity","volume":"2","author":"Bottazzo","year":"1983","journal-title":"Lancet"},{"key":"10.4158\/EP.1.1.14_bb0095","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/304071a0","article-title":"Lectin-induced expression of DR antigen on human cultured follicular thyroid cells","volume":"304","author":"Pujol-Borrell","year":"1983","journal-title":"Nature"},{"key":"10.4158\/EP.1.1.14_bb0100","first-page":"265","article-title":"Interferong induces HLA-DR expression by thyroid epithelium","volume":"61","author":"Todd","year":"1985","journal-title":"Clin Exp Immunol"},{"key":"10.4158\/EP.1.1.14_bb0105","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1210\/jcem-58-6-1166","article-title":"Adrenal dysfunction in asymptomatic patients with adrenocortical autoantibodies","volume":"58","author":"Ketchum","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.1.1.14_bb0110","doi-asserted-by":"crossref","first-page":"185","DOI":"10.7326\/0003-4819-111-2-185_1","article-title":"Adrenal insufficiency and interleukin-2 therapy","volume":"111","author":"VanderMolen","year":"1989","journal-title":"Ann Intern Med"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20404082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20404082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/3WY20JWKKYLE6U2A.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:15:46Z","timestamp":1761516946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20404082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1995,1]]}},"alternative-id":["S1530891X20404082"],"URL":"https:\/\/doi.org\/10.4158\/ep.1.1.14","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[1995,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune Addison\u2019s Disease after Treatment With interleukin-2 and Tumor-Infiltrating Lymphocytes","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP.1.1.14","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1995 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}